Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
CHEO Genetics Diagnostic Laboratory, |
RCV000769617 | SCV000901014 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2017-03-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002061044 | SCV002337027 | likely benign | Adams-Oliver syndrome 5 | 2024-12-24 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002061044 | SCV002555164 | likely benign | Adams-Oliver syndrome 5 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002271028 | SCV002555166 | likely benign | Aortic valve disease 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000769617 | SCV002726965 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2019-03-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |